EMA — authorised 24 July 2025
- Local brand name: Comirnaty
- Status: approved
EMA authorised Comirnaty on 24 July 2025
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 24 July 2025; EMA has authorised it.
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.